APVO logo

Aptevo Therapeutics (APVO) Free Cash Flow

Annual FCF

-$11.73 M
+$9.32 M+44.28%

December 31, 2023

Summary

Performance

1-Year Change

+44.28%

3-Year Change

+60.11%

5-Year Change

+77.61%

15-Year Change

+72.71%

APVO Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.97%
APVO annual free cash flow is higher than 59.97% of companies in Healthcare sector

High & Low

All-time High

-$11.73 M
APVO annual free cash flow is currently at an all-time high

3-Year Low

-$22.39 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
APVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
APVO next annual earnings announcement is scheduled for Mar 5, 2025

OtherAPVOcash flowmetrics:

Annual CFO

-$11.73 M
APVO annual cash flow from operations is -$11.73 million

Annual CFF

$6.00 M
APVO annual cash flow from financing activities is $6.00 million

Annual CFI

$0.00
APVO annual cash flow from investing activities is $0.00

Annual CAPEX

-
APVO annual capital expenditures value is unknown

Quarterly FCF

-$5.22 M
+$931.00 K+15.13%

September 30, 2024

Summary

Performance

3-Month Change

+15.13%

1-Year Change

+0.59%

3-Year Change

+0.59%

5-Year Change

-2.39%

APVO Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.98%
APVO quarterly free cash flow is higher than 45.98% of companies in Healthcare sector

High & Low

All-time High

$4.57 M
APVO quarterly free cash flow is currently -214.37% below its historical high of $4.57 million

3-Year Low

-$6.90 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
APVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
APVO next earnings announcement is scheduled for Mar 5, 2025

OtherAPVOcash flowmetrics:

Quarterly CFO

-$5.22 M
APVO quarterly cash flow from operations is -$5.22 million

Quarterly CFF

$4.91 M
APVO quarterly cash flow from financing activities is $4.91 million

Quarterly CFI

$0.00
APVO quarterly cash flow from investing activities is $0.00

Quarterly CAPEX

-
APVO quarterly capital expenditures value is unknown

TTM FCF

-$23.28 M
+$1.02 M+4.19%

September 30, 2024

Summary

Performance

3-Month Change

+4.19%

1-Year Change

-98.46%

3-Year Change

-98.46%

5-Year Change

+45.27%

APVO TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.32%
APVO TTM free cash flow is higher than 44.32% of companies in Healthcare sector

High & Low

All-time High

-$11.37 M

3-Year Low

-$24.30 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
APVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
APVO next earnings announcement is scheduled for Mar 5, 2025

OtherAPVOcash flowmetrics:

TTM CFO

-$23.28 M
APVO TTM cash flow from operations is -$23.28 million

TTM CFF

$11.92 M
APVO TTM cash flow from financing activities is $11.92 million

TTM CFI

$0.00
APVO TTM cash flow from investing activities is $0.00

TTM CAPEX

-
APVO TTM capital expenditures value is unknown

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$11.73 M
APVO annual free cash flow is -$11.73 million

Annual CFO

-$11.73 M
APVO annual cash flow from operations is -$11.73 million

Annual CAPEX

-
APVO annual capital expenditures value is unknown

APVO Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.3%+0.6%-98.5%
3 y3 years+60.1%+0.6%-98.5%
5 y5 years+77.6%-2.4%+45.3%

APVO Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+47.6%-214.4%+24.3%-104.8%+4.2%
5 y5-yearat high+72.4%-214.4%+53.3%-104.8%+45.3%
alltimeall timeat high+77.6%-214.4%+70.1%-104.8%+61.7%

Aptevo Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.22 M(-15.1%)
-$23.28 M(-4.2%)
Jun 2024
-
-$6.15 M(-7.5%)
-$24.30 M(+5.9%)
Mar 2024
-
-$6.65 M(+26.6%)
-$22.95 M(+95.6%)
Dec 2023
-$11.73 M(-44.3%)
-$5.25 M(-15.8%)
-$11.73 M(-5.5%)
Sep 2023
-
-$6.24 M(+29.9%)
-$12.42 M(-5.0%)
Jun 2023
-
-$4.80 M(-205.2%)
-$13.08 M(+15.0%)
Mar 2023
-
$4.57 M(-176.9%)
-$11.37 M(-46.0%)
Dec 2022
-$21.05 M(-6.0%)
-$5.94 M(-13.9%)
-$21.05 M(+10.2%)
Sep 2022
-
-$6.90 M(+122.9%)
-$19.11 M(+9.4%)
Jun 2022
-
-$3.10 M(-39.5%)
-$17.46 M(-11.9%)
Mar 2022
-
-$5.12 M(+28.0%)
-$19.81 M(-11.5%)
Dec 2021
-$22.39 M(-23.9%)
-$4.00 M(-23.9%)
-$22.39 M(-8.7%)
Sep 2021
-
-$5.25 M(-3.5%)
-$24.52 M(-8.0%)
Jun 2021
-
-$5.44 M(-29.3%)
-$26.65 M(+3.1%)
Mar 2021
-
-$7.70 M(+25.7%)
-$25.84 M(-11.9%)
Dec 2020
-$29.41 M(-30.9%)
-$6.12 M(-17.1%)
-$29.32 M(+3.6%)
Sep 2020
-
-$7.39 M(+59.4%)
-$28.30 M(-0.6%)
Jun 2020
-
-$4.63 M(-58.5%)
-$28.46 M(-28.3%)
Mar 2020
-
-$11.18 M(+119.1%)
-$39.71 M(-6.6%)
Dec 2019
-$42.54 M
-$5.10 M(-32.4%)
-$42.54 M(-5.0%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$7.55 M(-52.5%)
-$44.78 M(-8.1%)
Jun 2019
-
-$15.89 M(+13.5%)
-$48.73 M(-0.4%)
Mar 2019
-
-$14.00 M(+90.7%)
-$48.94 M(-6.6%)
Dec 2018
-$52.40 M(+21.9%)
-$7.34 M(-36.2%)
-$52.40 M(-13.8%)
Sep 2018
-
-$11.51 M(-28.5%)
-$60.77 M(+19.1%)
Jun 2018
-
-$16.10 M(-7.7%)
-$51.02 M(+7.2%)
Mar 2018
-
-$17.45 M(+11.0%)
-$47.60 M(+10.8%)
Dec 2017
-$42.98 M(+9.1%)
-$15.72 M(+797.7%)
-$42.98 M(+24.6%)
Sep 2017
-
-$1.75 M(-86.2%)
-$34.50 M(+5.1%)
Jun 2017
-
-$12.69 M(-1.1%)
-$32.84 M(-11.3%)
Mar 2017
-
-$12.82 M(+77.0%)
-$37.01 M(-6.0%)
Dec 2016
-$39.37 M(-21.7%)
-$7.24 M(+8131.8%)
-$39.37 M(-2.4%)
Sep 2016
-
-$88.00 K(-99.5%)
-$40.33 M(-19.4%)
Jun 2016
-
-$16.86 M(+11.0%)
-$50.03 M(+1.3%)
Mar 2016
-
-$15.18 M(+85.2%)
-$49.41 M(-1.7%)
Dec 2015
-$50.29 M(+4.8%)
-$8.20 M(-16.3%)
-$50.29 M(+19.5%)
Sep 2015
-
-$9.79 M(-39.7%)
-$42.09 M(+30.3%)
Jun 2015
-
-$16.23 M(+1.1%)
-$32.30 M(+101.1%)
Mar 2015
-
-$16.06 M
-$16.06 M
Dec 2014
-$48.00 M(-8.4%)
-
-
Dec 2013
-$52.41 M
-
-

FAQ

  • What is Aptevo Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Aptevo Therapeutics?
  • What is Aptevo Therapeutics annual FCF year-on-year change?
  • What is Aptevo Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Aptevo Therapeutics?
  • What is Aptevo Therapeutics quarterly FCF year-on-year change?
  • What is Aptevo Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Aptevo Therapeutics?
  • What is Aptevo Therapeutics TTM FCF year-on-year change?

What is Aptevo Therapeutics annual free cash flow?

The current annual FCF of APVO is -$11.73 M

What is the all time high annual FCF for Aptevo Therapeutics?

Aptevo Therapeutics all-time high annual free cash flow is -$11.73 M

What is Aptevo Therapeutics annual FCF year-on-year change?

Over the past year, APVO annual free cash flow has changed by +$9.32 M (+44.28%)

What is Aptevo Therapeutics quarterly free cash flow?

The current quarterly FCF of APVO is -$5.22 M

What is the all time high quarterly FCF for Aptevo Therapeutics?

Aptevo Therapeutics all-time high quarterly free cash flow is $4.57 M

What is Aptevo Therapeutics quarterly FCF year-on-year change?

Over the past year, APVO quarterly free cash flow has changed by +$31.00 K (+0.59%)

What is Aptevo Therapeutics TTM free cash flow?

The current TTM FCF of APVO is -$23.28 M

What is the all time high TTM FCF for Aptevo Therapeutics?

Aptevo Therapeutics all-time high TTM free cash flow is -$11.37 M

What is Aptevo Therapeutics TTM FCF year-on-year change?

Over the past year, APVO TTM free cash flow has changed by -$11.55 M (-98.46%)